Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2021

Pfizer Oncology - Complex Management of Relapsed and Refractory Multiple Myeloma (RRMM) and Evaluation of Unmet Needs

Q&A (Live)

Date

18 Sep 2021

Session

Pfizer Oncology - Complex Management of Relapsed and Refractory Multiple Myeloma (RRMM) and Evaluation of Unmet Needs

Presenters

Maria Mateos Gonzalez

Authors

N. Bahlis1, X. Leleu2, M. Mateos Gonzalez3

Author affiliations

  • 1 Foothills Medical Centre, T2N 2T9 - Calgary/CA
  • 2 Université de Poitiers, 86073 - Poitiers/FR
  • 3 CHUS - Hospital Clinico Universitario Santiago de Compostela, 15706 - Santiago de Compostela/ES

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Full session recording

Presenter: Xavier Leleu

Session: Pfizer Oncology - Complex Management of Relapsed and Refractory Multiple Myeloma (RRMM) and Evaluation of Unmet Needs

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.